A nomogram for preoperative risk evaluation of Bethesda III thyroid nodules.
BACKGROUND Bethesda Category III thyroid nodules (AUS/FLUS) pose a diagnostic challenge due to their malignancy rate of 15-30%. This study aimed to develop and validate a preoperative nomogram combining ultrasonographic features and BRAF V600E mutation status to enhance individualized risk assessment. METHODS We anal...